Cite
APA Citation
Nakaya, A., Fujita, S., Satake, A., Nakanishi, T., Azuma, Y., Tsubokura, Y., Hotta, M., Yoshimura, H., Ishii, K., Ito, T., & Nomura, S. (n.d.). delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?. Leukemia research, 50, 46–49. http://access.bl.uk/ark:/81055/vdc_100038845868.0x00002e